Cargando…
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation()
Dengue is a rapidly growing public health threat with approximately 2.5 billion people estimated to be at risk. Several vaccine candidates are at various stages of pre-clinical and clinical development. Thus far, live dengue vaccine candidates have been administered to several thousands of volunteer...
Autores principales: | Bentsi-Enchill, Adwoa D., Schmitz, Julia, Edelman, Robert, Durbin, Anna, Roehrig, John T., Smith, Peter G., Hombach, Joachim, Farrar, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355209/ https://www.ncbi.nlm.nih.gov/pubmed/23570986 http://dx.doi.org/10.1016/j.vaccine.2013.03.038 |
Ejemplares similares
-
Revised Global Typhoid Vaccination Policy
por: Bentsi-Enchill, Adwoa D, et al.
Publicado: (2019) -
A Turning Point in Typhoid Control
por: Bentsi-Enchill, Adwoa D, et al.
Publicado: (2018) -
Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022) -
Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines
por: Russell, Philip K., et al.
Publicado: (2016) -
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans
por: Nivarthi, Usha K., et al.
Publicado: (2021)